Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 180

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-21-2_007

تاریخ نمایه سازی: 27 مهر 1400

چکیده مقاله:

Objective(s): Micelles have been studied as nanoparticulate drug delivery systems for improving the topical ocular delivery of hydrophobic drugs. The objective of this study was to develop and characterize dexamethasone-loaded polycaprolactone-polyethylene glycol-polycaprolactone (PCL-PEG-PCL) micelles to improve patient compliance and enhance the ocular bioavailability of poorly water-soluble drugs. Materials and Methods: The PCL-PEG-PCL copolymers were synthesized via the ring opening polymerization of ε-caprolactone in the presence of PEG. The resulting purified copolymers were characterized by GPC, NMR, FTIR, XRD and DSC. The critical micelle concentrations (CMCs) of the copolymers mentioned were determined. Dexamethasone was loaded into polymeric micelles by film hydration method, and dexamethasone-loaded micelles were characterized by TEM and DLS. Drug release kinetics and ex vivo corneal permeability were also determined. Results: The CMC of the synthetized copolymers was approximately ۰.۰۳ mg/ml. Aqueous solutions of the resulting copolymers (۴۰۰ mg/ml) rapidly formed a gel in situ at ۳۴ °C. The TEM results exhibited the successful formation of spherical micelles. The size of the prepared micelles was approximately ۴۰ nm. Formulated micelles sustained the release of the incorporated dexamethasone for ۵ days. Conclusion: Data from ex vivo permeability tests indicated that PCL-PEG-PCL micelles can be suitable candidates for the ocular delivery of dexamethasone and, likely, other hydrophobic drugs.

نویسندگان

Mitra Alami-milani

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Parvin Zakeri-milani

Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Hadi Valizadeh

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Roya Salehi

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Mitra Jelvehgari

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱.Agrawal RV, Murthy S, Sangwan V, Biswas J. Current approach ...
  • ۲.Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of ...
  • ۳.Gonjari ID, Karmarkar AB, Khade TS, Hosmani AH, Navale RB. ...
  • ۴.Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. ...
  • ۵.Le Bourlais C, Acar L, Zia H, Sado PA, Needham ...
  • ۶.Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug ...
  • ۷.Pepiæ I, Lovriæ J, Filipoviæ-Grèiæ J. Polymeric micelles in ocular ...
  • ۸.Vaishya RD, Gokulgandhi M, Patel S, Minocha M, Mitra AK. ...
  • ۹.Tiffany JM. Tears in health and disease. Eye ۲۰۰۳; ۱۷:۹۲۳-۹۲۶ ...
  • ۱۰.Zhang W, Prausnitz MR, Edwards A. Model of transient drug ...
  • ۱۱.Kopeček J, Kopečková P, Minko T, Lu ZR, Peterson CM. ...
  • ۱۲.Vargas A, Pegaz B, Debefve E, Konan-Kouakou Y, Lange N, ...
  • ۱۳.Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Kiafar F, ...
  • ۱۴.Ideta R, Tasaka F, Jang WD, Nishiyama N, Zhang GD, ...
  • ۱۵.Jang WD, Nakagishi Y, Nishiyama N, Kawauchi S, Morimoto Y, ...
  • ۱۶.Takeuchi Y, Ichikawa K, Yonezawa S, Kurohane K, Koishi T, ...
  • ۱۷.Vaishya RD, Khurana V, Patel S, Mitra AK. Controlled ocular ...
  • ۱۸.Trivedi R, Kompella UB. Nanomicellar formulations for sustained drug delivery: ...
  • ۱۹.Vadlapudi AD, Mitra AK. Nanomicelles: an emerging platform for drug ...
  • ۲۰.Boddu SH, Jwala J, Vaishya R, Earla R, Karla PK, ...
  • ۲۱.Gómez-Gaete C, Tsapis N, Besnard M, Bochot A, Fattal E. ...
  • ۲۲.Bae SJ, Suh JM, Sohn YS, Bae YH, Kim SW, ...
  • ۲۳.Ma G, Miao B, Song C. Thermosensitive PCL-PEG-PCL hydrogels: synthesis, ...
  • ۲۴.Zhou S, Deng X, Yang H. Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) block ...
  • ۲۵.Liu CB, Gong CY, Huang MJ, Wang JW, Pan YF, ...
  • ۲۶.Alkhalidi BA, Alkhatib HS, Khdair AA. Comparative dissolution of diltiazem ...
  • ۲۷.Elsayed I, Abdelbary AA, Elshafeey AH. Nanosizing of a poorly ...
  • ۲۸.Mpharm KD, Ramana MV, Sara UV, Agrawal DK, Mpharm KP, ...
  • ۲۹.Nguyen THA, Nguyen VC. Formation of nanoparticles in aqueous solution ...
  • ۳۰.Barghi L, Asgari D, Barar J, Valizadeh H. Synthesis of ...
  • ۳۱.Tamboli V, Mishra GP, Mitra AK. Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA)-based ...
  • ۳۲.Savla S, Surjusee A, Rokade V, Sawant S, Kadu P. ...
  • ۳۳.Sareen S, Mathew G, Joseph L. Improvement in solubility of ...
  • ۳۴.Kaihara S, Fisher JP, Matsumura S. Chemo-enzymatic synthesis of degradable ...
  • ۳۵.Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. ...
  • ۳۶.Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology ...
  • ۳۷.Lee VHL, Robinson JR. Topical ocular drug delivery: recent developments ...
  • ۳۸.Aksungur P, Demirbilek M, Denkbaş EB, Vandervoort J, Ludwig A, ...
  • ۳۹.Mandal A, Bisht R, Rupenthal ID, Mitra AK. Polymeric micelles ...
  • نمایش کامل مراجع